Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta- and gamma-catenin expression in thyroid carcinomas

A Cerrato1, F Fulciniti, A Avallone

  • 1Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Reggio Calabria, Catanzaro, Italy.

The Journal of Pathology
|October 15, 1998
PubMed
Summary

Cadherins and catenins, crucial for cell adhesion, are frequently down-regulated in thyroid carcinomas. This study highlights their altered expression, suggesting roles as tumor markers in thyroid cancer progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cisplatin-gemcitabine-durvalumab reintroduction in advanced biliary tract cancer: a multinational real-world analysis.

ESMO open·2026
Same author

Anti-EGFR-based maintenance versus stop and go in patients with left-sided, non-MSI-H, RAS/BRAF-wt metastatic colorectal cancer: individual patient data pooled analysis.

ESMO open·2026
Same author

Baseline neutrophil-to-eosinophil ratio and neutrophil-to-lymphocyte ratio as prognostic markers in patients with unresectable biliary tract cancer treated with gemcitabine-cisplatin-durvalumab: an international, multicentre, retrospective cohort study.

ESMO gastrointestinal oncology·2026
Same author

Video vignette: robotic ileocolic resection for Crohn's disease with enterocutaneous fistula takedown.

Techniques in coloproctology·2026
Same author

<i>HER-2</i> gene alterations as biomarker in patients with metastatic colorectal cancer treated with FOLFIRI + cetuximab: findings from the CAPRI-2 GOIM study.

ESMO gastrointestinal oncology·2026
Same author

Clinical and translational results from the phase II ABACO trial evaluating the activity of cabozantinib in pretreated patients with metastatic colorectal cancer.

ESMO gastrointestinal oncology·2026

Area of Science:

  • Cellular biology
  • Molecular oncology
  • Biochemistry

Background:

  • Cadherins are calcium-dependent cell-cell adhesion molecules.
  • Their function involves a complex with catenins.
  • Down-regulation of cadherins is linked to human carcinoma progression.

Purpose of the Study:

  • To investigate the immunohistochemical expression of E-cadherin, beta-catenin, and gamma-catenin in human thyroid carcinomas.
  • To determine if catenins are altered at cell-cell junctions in thyroid tumors.
  • To assess the potential of these molecules as differentiation or transformation markers.

Main Methods:

  • Immunohistochemical analysis of E-cadherin, beta-catenin, and gamma-catenin expression.
  • Study included 27 human thyroid carcinoma samples.

Related Experiment Videos

  • Comparison of protein expression in tumor tissue versus normal tissue.

    • Main Results:

    • Decreased E-cadherin immunoreactivity observed in 53% of papillary, 71% of follicular, and 100% of anaplastic carcinomas.
    • Reduced beta-catenin membrane localization found in 40% of papillary, 28% of follicular, and 100% of anaplastic carcinomas.
    • Partial or total loss of gamma-catenin expression occurred in 86% of papillary, 85% of follicular, and 100% of anaplastic carcinomas.

    Conclusions:

    • E-cadherin and catenins (beta- and gamma-catenin) are down-regulated at cell-cell junctions in thyroid tumors.
    • These molecules may serve as useful differentiation and/or transformation markers in thyroid carcinomas.
    • The high frequency of gamma-catenin alterations suggests a significant role in thyroid carcinogenesis.